Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran.
Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
BMC Infect Dis. 2024 Sep 18;24(1):999. doi: 10.1186/s12879-024-09872-2.
Reinfection with SARS-Cov-2 after recovery can occur that most of them don't require hospitalization. The aim of this study is estimation of out-patient COVID-19 reinfection and recurrence rates and its associated factors among Iranian patients with history of confirmed SARS-Cov-2 infection and hospitalization.
This study is a retrospective cohort conducted from May 2021 to May 2022 in Iran. The national Medical Care Monitoring Center (MCMC) database, obtained from the Ministry of Health and Medical Education, includes all information about confirmed COVID-19 patients who are hospitalized and diagnosed during the pandemic. Using probability proportional to size sampling from 31 provinces, 1,532 patients over one years of age with a history of hospitalization in the MCMC data are randomly selected. After that, interviews by phone are performed with all of the selected patients using a researcher-made questionnaire about the occurrence of overall reinfection without considering the time of infection occurrence, reinfection occurring at least 90 days after the discharge and recurrence (occurring within 90 days after discharge). Univariate and multivariable Cox regression analyses are performed to assess the factors associated with each index. All of the analyses are performed using Stata software version 16.
In general, 1,532 phone calls are made, out of which 1,095 individuals are willing to participate in the study (response rate ≃ 71%). After assessing the 1,095 patients with a positive history of COVID-19, the rates of non-hospitalized overall SARS-Cov-2 reinfection, reinfection and recurrence are 122.64, 114.09, and 8.55 per 1,000 person-years, respectively. The age range of 19-64 years (aHR:3.93, 95%CI : 1.24-12.41) and COVID-19-related healthcare worker (aHR: 3.67, 95%CI: 1.77-7.61) are identified as risk factors for reinfection, while having comorbidity, being fully vaccinated, and having a partial pressure of oxygen (PaO2) ≥ 93 mmHg during the initial infection are identified as factors that reduce the risk of non-hospitalized reinfection.
Reinfection due to COVID-19 is possible because of the weakened immune system for various reasons and the mutation of the virus. Vaccination, timely boosters, and adherence to preventive measures can help mitigate this risk.
在康复后,SARS-CoV-2 的再次感染是可能发生的,其中大多数不需要住院治疗。本研究的目的是评估伊朗有确诊 SARS-CoV-2 感染和住院史的患者的门诊 COVID-19 再感染和复发率及其相关因素。
本研究是 2021 年 5 月至 2022 年 5 月在伊朗进行的回顾性队列研究。国家医疗保健监测中心(MCMC)数据库来自卫生部和教育部,其中包含在大流行期间住院和诊断的所有确诊 COVID-19 患者的信息。采用比例概率抽样方法,从 31 个省份中随机抽取 1532 名年龄在 1 岁以上、MCMC 数据中有住院史的患者。之后,使用研究人员制作的问卷对所有选定的患者进行电话访谈,内容涉及整体再感染(不考虑感染发生时间)、出院后至少 90 天发生的再感染和复发(出院后 90 天内发生)。采用单变量和多变量 Cox 回归分析评估与每个指标相关的因素。所有分析均使用 Stata 软件版本 16 进行。
一般来说,共拨打了 1532 个电话,其中 1095 人愿意参与研究(应答率≈71%)。在评估了 1095 名有 COVID-19 阳性史的患者后,非住院 SARS-CoV-2 整体再感染、再感染和复发的发生率分别为 122.64、114.09 和 8.55/1000 人年。19-64 岁年龄组(aHR:3.93,95%CI:1.24-12.41)和与 COVID-19 相关的医护人员(aHR:3.67,95%CI:1.77-7.61)被确定为再感染的危险因素,而合并症、完全接种疫苗以及初次感染时的血氧分压(PaO2)≥93mmHg 被确定为降低非住院再感染风险的因素。
由于各种原因导致的免疫系统减弱和病毒突变,COVID-19 可能会再次感染。接种疫苗、及时加强针和遵守预防措施可以帮助降低这种风险。